Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.
Stockhead on MSN4d
Island completes dosing in phase 2b arm of mosquito-borne dengue trialIsland Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial ...
Hosted on MSN4d
AbViro launches NIH-funded dengue challenge trialThe trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback